Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sera Prognostics (SERA) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Sera Prognostics (SERA) over the last 6 years, with Q3 2025 value amounting to $4.1 million.

  • Sera Prognostics' Cash & Equivalents rose 5204.92% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 5204.92%. This contributed to the annual value of $4.0 million for FY2024, which is 420.1% up from last year.
  • As of Q3 2025, Sera Prognostics' Cash & Equivalents stood at $4.1 million, which was up 5204.92% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Sera Prognostics' Cash & Equivalents ranged from a high of $90.9 million in Q2 2021 and a low of $2.7 million during Q3 2024
  • For the 5-year period, Sera Prognostics' Cash & Equivalents averaged around $29.0 million, with its median value being $18.4 million (2023).
  • Per our database at Business Quant, Sera Prognostics' Cash & Equivalents skyrocketed by 33546.89% in 2021 and then tumbled by 8701.39% in 2023.
  • Over the past 5 years, Sera Prognostics' Cash & Equivalents (Quarter) stood at $58.9 million in 2021, then plummeted by 49.3% to $29.9 million in 2022, then plummeted by 87.01% to $3.9 million in 2023, then rose by 4.2% to $4.0 million in 2024, then grew by 0.94% to $4.1 million in 2025.
  • Its Cash & Equivalents was $4.1 million in Q3 2025, compared to $5.0 million in Q2 2025 and $5.2 million in Q1 2025.